Tel:626-887-5831
Mail:info@asimicrofluidizer.com
Application of pharmaceutical homogenization
In the fields of nanoemulsions, dispersions, microencapsulation, and cell disruption, Mnano's innovative jet-impact homogenization system enables uniform reduction of product particle size. Our global corporate clients including GSK, Merck, Novartis, Pfizer, Teva Pharmaceuticals, Lota Nano, Rhodia, and Wyeth Pharmaceuticals utilize this equipment to develop and produce renowned drugs and vaccines currently on the market.
Within pharmaceutical research, numerous institutions worldwide employ our products, such as:
University of Oxford (UK)
University of Cambridge (UK)
UK Cancer Drug Discovery Center (UK)
University of Barcelona (Spain)
University of Victoria (Spain)
University of Georgia (USA)
The Ohio State University (USA)
Applications include vaccines/adjuvants, cancer therapeutics, antibiotics, injectables, adsorbents, anesthetics, steroids, and more.
| Typical product | Pressure range(MPa) | Pressure range(PSI) |
| Liposome | 20 —150 | 3,000—22,000 |
| Encapsulate | 20 —150 | 3,000—22,000 |
| Nanoemulsion | 20 —200 | 3,000—30,000 |
| Lipid Nanoparticles | 50 —200 | 7,000—30,000 |
| Dissociation, dispersion | 20 —350 | 3,000—50,000 |
| Nanoparticle suspensions, such as carbon nanotubes | 20 —400 | 3,000—60,000 |
Microfluidizer Nanotechnology Limited, Company number: 13114417
| 
|
ADD：Office Suite 29A, 3/F 23 Wharf Street London ,United Kingdom,SE83GG 
WEB：www.aquariusscientific.com
EMAIL：admin@